Epitopes for Multivalent Vaccines Against


Journal

Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359

Informations de publication

Date de publication:
2020
Historique:
received: 16 06 2020
accepted: 30 09 2020
entrez: 16 11 2020
pubmed: 17 11 2020
medline: 22 6 2021
Statut: epublish

Résumé

The glycolytic enzyme and bacterial virulence factor of

Identifiants

pubmed: 33194812
doi: 10.3389/fcimb.2020.573348
pmc: PMC7657268
doi:

Substances chimiques

Epitopes 0
Vaccines, Combined 0
Glyceraldehyde-3-Phosphate Dehydrogenases EC 1.2.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

573348

Informations de copyright

Copyright © 2020 Alvarez-Dominguez, Salcines-Cuevas, Teran-Navarro, Calderon-Gonzalez, Tobes, Garcia, Grijalvo, Paradela, Seoane, Sangari, Fresno, Calvo-Montes, Pérez Del Molino Bernal and Yañez-Diaz.

Références

Traffic. 2008 Mar;9(3):325-37
pubmed: 18088303
Nanomaterials (Basel). 2016 Aug 19;6(8):
pubmed: 28335280
Nucleic Acids Res. 2012 Jul;40(Web Server issue):W525-30
pubmed: 22610854
Mol Cell. 2015 Jul 16;59(2):309-20
pubmed: 26166706
Clin Infect Dis. 2017 Feb 15;64(4):501-509
pubmed: 28172588
Infect Immun. 2008 Dec;76(12):5478-87
pubmed: 18852239
Nat Commun. 2014 Aug 28;5:4730
pubmed: 25163484
Infect Immun. 2001 Sep;69(9):5329-34
pubmed: 11500402
J Immunol Methods. 2015 Jan;416:105-23
pubmed: 25445329
Oncotarget. 2017 Jul 20;8(33):53916-53934
pubmed: 28903312
Infez Med. 2017 Sep 1;25(3):210-216
pubmed: 28956537
Immun Ageing. 2018 Jan 22;15:3
pubmed: 29387135
BMC Bioinformatics. 2005 May 31;6:132
pubmed: 15927070
Protein Sci. 2003 May;12(5):1007-17
pubmed: 12717023
Microbiol Mol Biol Rev. 2013 Jun;77(2):173-207
pubmed: 23699254
J Biol Chem. 2017 Feb 10;292(6):2217-2225
pubmed: 28011643
Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W509-12
pubmed: 18463140
Vaccine. 2012 Mar 30;30(16):2633-9
pubmed: 22365841
PLoS Pathog. 2016 Apr 13;12(4):e1005561
pubmed: 27074026
Cell Microbiol. 2019 Mar;21(3):e12988
pubmed: 30511471
J Immunol Methods. 2015 Sep;424:111-9
pubmed: 26031451
J Biol Chem. 2012 Dec 14;287(51):42620-33
pubmed: 23086952
PLoS One. 2017 Jul 25;12(7):e0181942
pubmed: 28742838
Bioinformatics. 2016 Feb 15;32(4):511-7
pubmed: 26515819
Cell Microbiol. 2014 Sep;16(9):1311-20
pubmed: 24948362
Front Cell Infect Microbiol. 2014 Feb 21;4:22
pubmed: 24600592
Euro Surveill. 2019 May;24(21):
pubmed: 31138365
Immunome Res. 2008 Jan 25;4:2
pubmed: 18221540
Front Cell Infect Microbiol. 2017 Jun 08;7:245
pubmed: 28642848
EMBO Mol Med. 2020 Jun 8;12(6):e12661
pubmed: 32379923
Immunity. 2006 May;24(5):491-4
pubmed: 16713963
Front Immunol. 2016 Nov 29;7:541
pubmed: 27965668

Auteurs

Carmen Alvarez-Dominguez (C)

Grupo de Oncología y Nanovacunas, Instituto de Investigación Marqués de Valdecilla, Santander, Spain.
Facultad de Educación, Universidad Internacional de La Rioja, Logroño, Spain.

David Salcines-Cuevas (D)

Grupo de Oncología y Nanovacunas, Instituto de Investigación Marqués de Valdecilla, Santander, Spain.

Héctor Teran-Navarro (H)

Grupo de Oncología y Nanovacunas, Instituto de Investigación Marqués de Valdecilla, Santander, Spain.

Ricardo Calderon-Gonzalez (R)

Grupo de Oncología y Nanovacunas, Instituto de Investigación Marqués de Valdecilla, Santander, Spain.

Raquel Tobes (R)

Independent Researcher, Granada, Spain.

Isabel Garcia (I)

Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Barcelona, Spain.
CIC biomaGUNE, Basque Research and Technology Alliance (BRTA), Donostia-San Sebastian, Spain.

Santiago Grijalvo (S)

Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Barcelona, Spain.
Department of Surfactants and Nanobiotechnology, Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), Barcelona, Spain.

Alberto Paradela (A)

Centro Nacional de Biotecnología, CSIC, Madrid, Spain.

Asunción Seoane (A)

Department of Molecular Biology, Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC, CSIC-Universidad de Cantabria-SODERCAN), Santander, Spain.
Facultad de Medicina, Universidad de Cantabria, Santander, Spain.

Felix J Sangari (FJ)

Department of Molecular Biology, Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC, CSIC-Universidad de Cantabria-SODERCAN), Santander, Spain.
Facultad de Medicina, Universidad de Cantabria, Santander, Spain.

Manuel Fresno (M)

Department of Molecular Biology, DIOMUNE S.L., Madrid, Spain.
Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid, Madrid, Spain.

Jorge Calvo-Montes (J)

Servicio de Microbiología, Hospital Universitario Marqués de Valdecilla, Santander, Spain.

I Concepción Pérez Del Molino Bernal (IC)

Servicio de Microbiología, Hospital Universitario Marqués de Valdecilla, Santander, Spain.

Sonsoles Yañez-Diaz (S)

Grupo de Oncología y Nanovacunas, Instituto de Investigación Marqués de Valdecilla, Santander, Spain.
Servicio de Dermatología, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Departamento de Medicina y Cirugia, Facultad de Medicina, Universidad de Cantabria, Santander, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH